Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PDS Biotechnology
PDS Biotechnology
Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal
Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal
Fierce Biotech
Merck KGaA
R&D
PDS Biotechnology
Flag link:
ASCO 2021 movers – PDS wins, but big pharma reigns
ASCO 2021 movers – PDS wins, but big pharma reigns
EP Vantage
ASCO 2021
PDS Biotechnology
Spectrum Pharma
Black Diamond Therapeutics
Alpine Immune Sciences
Harpoon Therapeutics
Macrogenics
Flag link:
PDS Biotechnology Files for $14 Million Offering
PDS Biotechnology Files for $14 Million Offering
CP WIre
PDS Biotechnology
PDS0101
HPV head and neck cancer
Flag link:
PDS Biotechnology Files for $14 Million Offering
PDS Biotechnology
PDS0101
HPV head and neck cancer
Flag link:
After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS
After Head Injury Drug Fails, Edge Merges with Immuno-Oncology Firm PDS
Xconomy
Edge Therapeutics
head injury
clinical trials
M&A
PDS Biotechnology
immuno-oncology
Flag link:
